These mice conditionally express an L858R mutation of the Egfr (epidermal growth factor receptor) gene associated with a subset of non-small cell lung cancers in humans. A floxed Stop cassette blocks expression of Egfr until it is excised with Cre recombinase.
Dr. Tyler Jacks, Massachusetts Institute of Technology
Egfr (epidermal growth factor receptor) is a transmembrane protein in the erbB family of tyrosine kinase receptors. Extracellular ligands such as epidermal growth factor (EGF) and transforming growth factor-α (TGF-α) bind EGFR and induce receptor dimerization, autophosphorylation and activation of signal transduction pathways. Mutations in the kinase domain of EGFR, among them L858R (leucine to arginine), are associated with approximately 10% of non-small cell lung cancers (NSCLCs) in the United States and with approximately 35% of cases in Asia.
In this mutant mouse strain, a loxP-flanked Stop cassette(LSL) located in intron 1 of Egfr blocks expression of the gene. Homozygous floxed mice express no EGFR protein are not viable, mimicking the phenotype of the Egfr knockout mice. Upon Cre-mediated excision of the floxed stop cassette, the L858R mutant form of the protein is expressed, albeit at levels lower than those found in wildtype mice. This reduced expression is thought to be the result of the mutant protein being constitutively active and engaging a negative feedback loop which results in its degradation.
When mutant protein expression is directed to the lung (via adeno-cre or lentiviral-cre excision of the LSL-cassette), mice fail to develop the anticipated lung tumors. Most human patients with EGFR mutations have amplification of the gene in their tumors, suggesting that both mutation and overexpression are required for tumor development. If the stop cassette is deleted in the germline, mice develop a wavy coat characteristic of other Egfr mutations and are also reduced in body size. These mice also develop low grade liver lesions at a late time point. Mutant mice lacking the stop cassette are viable as homozygotes.
This strain was constructed with a two-step targeting approach. A construct containing an FRT-neo-FRT cassette in intron 20 and a T->G point mutation in exon 21 was targeted to the Egfr locus in C57BL/6-derived v26.2 embryonic stem (ES) cells. The ES cells were then re-targeted to place a lox-Stop-lox (LSL) cassette in intron 1 of Egfr. ES cells carrying both targeting events in cis were then selected for embryo injection. Germline mice were crossed to a C57BL/6 background Flpe deleter line to remove the FRT-neo-FRT cassette. This strain was maintained on a mixed genetic backgound that involves 129 and C57BL/6 by the donating laboratory.
|Allele Name||targeted mutation 1.1, Tyler Jacks|
|Allele Synonym(s)||targeted mutation 1.1, Tyler Jacks; Egfrtm1.1Tyj|
|Gene Symbol and Name||Egfr, epidermal growth factor receptor|
|Gene Synonym(s)||Erbb; avian erythroblastosis oncogene B; mENA; ERBB1; HER1; 9030024J15Rik; AI552599; Wa5; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; RIKEN cDNA 9030024J15 gene; 9030024J15Rik; PIG61; ERBB; expressed sequence AI552599; Errb1; wa-2; wa2; Wa5; waved 2; waved 5; NISBD2; ErbB-1; Errp; Erbb|
|Strain of Origin||C57BL/6|
|Molecular Note||The targeting construct introduced an FRT-neo-FRT cassette into intron 20 and a T->G point mutation in exon 21. The point mutation resulted in the amino acid substitution of arginine for lysine at position 858 (L858R). The locus was re-targeted to place a lox-Stop-lox (LSL) cassette in intron 1. Flp-mediated recombination removed the neo cassette.|
Homozygous floxed stop (LSL) animals are not viable as they are in essence null for Egfr which is known to be incompatible with development. Mutant mice lacking the stop cassette can be bred to homozygosity and are viable.
When using the STOCK Egfrtm1.1Tyj/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #018473 in your Materials and Methods section.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.